retatrutide glp-1 gip glucagon receptor agonist What Is (RETA)? The Triple Explained Retatrutide 10mg — Triple Receptor

Description

One retrospective study analyzed the association of semaglutide and tirzepatide use with weight loss in patients with early breast cancer (stage IIII)

Bergenstal RM, Forti A, Chiasson JL, Woloschak M, Boldrin M, Balena R

Additionally, tirzepatide was found to have a more pronounced effect compared with the GLP-1 agonist semaglutide in people with T2DM

This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription 17.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access 169.00 per year only 14.08 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout References Parker, J

Genetic Testing to Personalize Your GLP-1 Choice PlexusDx Precision Peptide Genetic Test analyzes 14 metabolic pathways and 49 peptides to reveal how your genetic variants influence weight regulation and GLP-1 response